Comparative investigation of antitumoral effectiveness of Rho-kinase inhibitor Y-27632, pravastatin and atorvastatin in anaplastic thyroid cancer cell culture
Anaplastic thyroid cancer is an aggressive malignancy with a poor prognosis. In metastatic cases instead of treatment alternatives including surgery, radiotherapy, and chemotherapeutic regimens, targeted treatments should be sought for. Statins are 3-hidroxy-3 methylglutaryl-coenzyme A (HMG-CoA) red...
Saved in:
Main Authors: | Erdinc Nayir, Selver Cor, Zuhal Mert Altintas, Kansu Buyukafsar, Rukiye Nalan Tiftik, Alper Ata, Ali Arican |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2017-07-01
|
Series: | Journal of Oncological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452336417300456 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMBINED CHEMOTHERAPY INCLUDING PROCARBAZINE (NATULAN) IN THE TREATMENT OF ANAPLASTIC OLIGODENDROGLIOMAS
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01) -
Keratinocyte-derived VEGF-A is an essential pro-migratory autocrine mediator, acting through the KDR/GEF-H1/RhoA pathway
by: Vida Maksimoska, et al.
Published: (2025-07-01) -
The Rho/MRTF-pirin axis: a promising target for overcoming melanoma drug resistance
by: Xiaoyan Chen, et al.
Published: (2025-07-01) -
New opportunities for preoperative diagnosis of anaplastic thyroid cancer
by: S. A. Lukyanov, et al.
Published: (2021-04-01) -
Targeted therapy of anaplastic thyroid cancer
by: P. A. Nikiforovich, et al.
Published: (2023-03-01)